In this video on OncoDaily TV, host Dr. Shushan Hovsepyan sits down with Tommy Bramley, Senior Vice President of Global Consulting at Cencora, to discuss how the launch of innovative oncology therapies has evolved in today’s increasingly complex healthcare environment.
As cancer treatments become more personalized and technologically advanced, including CAR-T therapies, bispecific antibodies, and precision medicines – bringing these innovations to patients requires far more than regulatory approval.
Mr. Bramley explains why successful launches now depend on coordinating entire healthcare systems, generating strong evidence for regulators and payers, leveraging real-world evidence, and overcoming reimbursement and logistical barriers that can delay patient access by years.
The conversation also explores leadership, global market access strategies, and what pharmaceutical companies can do earlier in development to ensure patients receive life-saving treatments sooner.